Aquestive Therapeutics (AQST) just unveiled an update.
Aquestive Therapeutics, Inc. has elevated Cassie Jung to the role of Chief Operating Officer, recognizing her extensive experience and contributions within the company since 2004. Jung, who has been pivotal in areas such as Quality Assurance and Operations, will now oversee the operational strategies of the firm with an increased base salary and eligibility for incentive programs. Her promotion reflects her proven leadership skills and the company’s confidence in her ability to drive future success without any familial or undisclosed financial ties influencing the decision.
For an in-depth examination of AQST stock, go to TipRanks’ Stock Analysis page.
